Knowles Julius Insider Trading Activity

Average Profitability
122.73%
Insider Buys Quantity
1
Insider Buys Sum
$24,987.18
Insider Sells Quantity
38
Insider Sells Sum
$30.48M

Insider Activity of Knowles Julius

According to the SEC Form 4 filings, Knowles Julius, being in a position of

  1. director at Keros Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2625 shares for $28,166,
    over all time since 2020-04-13, has bought 1191 share for $24,987, and sold 601971 share for $30.51M.

Biography of Knowles Julius

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$28,1661100

Comparison of Insiders on Amount of Buys and Sells

2026-06-04SaleKeros Therapeutics, Inc.
KROS
director
2,625
0.0082%
$10.73$28,166+2.51%
2022-01-05SaleKeros Therapeutics, Inc.
KROS
director
4,034
0.0174%
$58.25$234,991-18.81%
2022-01-04SaleKeros Therapeutics, Inc.
KROS
director
20,062
0.082%
$57.55$1.15M-21.81%
2022-01-03SaleKeros Therapeutics, Inc.
KROS
director
23,555
0.0959%
$58.01$1.37M-22.56%
2021-12-02SaleKeros Therapeutics, Inc.
KROS
director
25,338
0.1068%
$53.57$1.36M-14.99%
2021-12-01SaleKeros Therapeutics, Inc.
KROS
director
22,313
0.0981%
$54.68$1.22M-13.08%
2021-11-03SaleKeros Therapeutics, Inc.
KROS
director
15,967
0.0688%
$41.95$669,780+12.71%
2021-11-02SaleKeros Therapeutics, Inc.
KROS
director
7,881
0.0337%
$42.40$334,149+10.47%
2021-11-01SaleKeros Therapeutics, Inc.
KROS
director
23,803
0.1%
$42.15$1M+8.8%
2021-10-20SaleKeros Therapeutics, Inc.
KROS
director
4,082
0.0175%
$38.24$156,095+20.78%
2021-10-19SaleKeros Therapeutics, Inc.
KROS
director
4,516
0.0193%
$38.16$172,346+20.91%
2021-10-18SaleKeros Therapeutics, Inc.
KROS
director
13,786
0.0586%
$37.70$519,711+21.74%
2021-10-15SaleKeros Therapeutics, Inc.
KROS
director
8,198
0.0351%
$39.16$321,052+17.95%
2021-10-14SaleKeros Therapeutics, Inc.
KROS
director
4,383
0.0188%
$40.13$175,890+15.36%
2021-10-05SaleKeros Therapeutics, Inc.
KROS
director
2,617
0.0112%
$40.03$104,759+13.06%
2021-10-04SaleKeros Therapeutics, Inc.
KROS
director
3,746
0.0163%
$40.06$150,065+14.46%
2021-10-01SaleKeros Therapeutics, Inc.
KROS
director
6,323
0.0271%
$40.16$253,932+15.23%
2021-09-27SaleKeros Therapeutics, Inc.
KROS
director
95,302
0.3843%
$41.17$3.92M+3.02%
2021-07-02SaleKeros Therapeutics, Inc.
KROS
director
23,818
0.1028%
$41.34$984,565+12.2%
2021-07-01SaleKeros Therapeutics, Inc.
KROS
director
23,834
0.1022%
$41.28$983,787+9.24%
Total: 40
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.